Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Kewpie Corporation has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. Each of these 4 pending office actions is assigned to a different person, as there are 4 distinct examiners involved. Furthermore, the actions are distributed across 4 distinct art units, indicating a broad spread of technical classifications. CHANG, KYUNG SOOK is the busiest examiner, currently holding 1 busiest examiner pending action. This one-to-one ratio between actions, examiners, and art units suggests that the company's biotechnology filings are diverse and handled independently.
With 4 distinct art units, the company must navigate four different sets of examination practices. The presence of 4 distinct examiners means that no single individual has oversight of more than one pending case. Practitioners should be prepared to manage 4 distinct examiners who may have different interpretations of the 4 pending office actions. This distribution across 4 distinct art units requires monitoring of different examination styles and procedural nuances. The presence of 4 distinct examiners for 4 actions shows that each pending matter is receiving independent review. This level of dispersion requires a robust tracking system to maintain consistency across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (50%) |
| §103 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANG, KYUNG SOOK | 1 | 60.5% | +40.8% |
| SHIAO, YIH-HORNG | 1 | 72.6% | +75.9% |
| SABILA, MERCY HELLEN | 1 | 57.5% | +45.3% |
| LIN, JERRY | 1 | 72.2% | +14.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18714279 | HYALURONIC ACID POWDER | SHIAO, YIH-HORNG | — |
| 17996372 | IMAGE GENERATION DEVICE, DISPLAY DEVICE, DATA CONVERSION DEVICE, IMAGE GENERATION METHOD, PRESENTATION METHOD, DATA CONVERSION METHOD, AND PROGRAM | LIN, JERRY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18874081 | Lipid Nanoparticles and Production Method for Same | CHANG, KYUNG SOOK | — |
| 18714279 | HYALURONIC ACID POWDER | SHIAO, YIH-HORNG | — |
| 18567426 | Preparation | SABILA, MERCY HELLEN | — |
| 17996372 | IMAGE GENERATION DEVICE, DISPLAY DEVICE, DATA CONVERSION DEVICE, IMAGE GENERATION METHOD, PRESENTATION METHOD, DATA CONVERSION METHOD, AND PROGRAM | LIN, JERRY | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 1691 | 1 |
| 1654 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18874081 | Lipid Nanoparticles and Production Method for Same | CHANG, KYUNG SOOK | 1613 | §103 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18714279 | HYALURONIC ACID POWDER | SHIAO, YIH-HORNG | 1691 | §101§102§103§112 | Non-Final OA | — | Pending | May 29, 2024 |
| 18567426 | Preparation | SABILA, MERCY HELLEN | 1654 | §102DP | Final Rejection | — | Pending | Dec 06, 2023 |
| 17996372 | IMAGE GENERATION DEVICE, DISPLAY DEVICE, DATA CONVERSION DEVICE, IMAGE GENERATION METHOD, PRESENTATION METHOD, DATA CONVERSION METHOD, AND PROGRAM | LIN, JERRY | 1685 | §101§102 | Non-Final OA | — | Pending | Oct 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKewpie Corporation has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Kyung Sook Chang has the most, with 1 of Kewpie Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
